Sanifit Appoints Adam Levy as Chief Financial Officer
August 20, 2020 07:00 ET
|
Laboratoris Sanifit S.L.
Sanifit Appoints Adam Levy as Chief Financial Officer Palma, Spain and San Diego, USA, 20 August 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for...
First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis
February 13, 2020 07:00 ET
|
Laboratoris Sanifit S.L.
First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis First patient dosed in phase 3 trial of SNF472 for the treatment of calcific uremic arteriolopathy (CUA) or calciphylaxis ...
Laboratoris Sanifit S.L.: Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
October 23, 2018 07:00 ET
|
Laboratoris Sanifit S.L.
Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris...
Laboratoris Sanifit S.L.: Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
October 23, 2018 02:00 ET
|
Laboratoris Sanifit S.L.
Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris...